1. Home
  2. ORIC vs SEAT Comparison

ORIC vs SEAT Comparison

Compare ORIC & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • SEAT
  • Stock Information
  • Founded
  • ORIC 2014
  • SEAT 2001
  • Country
  • ORIC United States
  • SEAT United States
  • Employees
  • ORIC N/A
  • SEAT N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • SEAT Industrial Machinery/Components
  • Sector
  • ORIC Health Care
  • SEAT Industrials
  • Exchange
  • ORIC Nasdaq
  • SEAT Nasdaq
  • Market Cap
  • ORIC 362.9M
  • SEAT 366.2M
  • IPO Year
  • ORIC 2020
  • SEAT N/A
  • Fundamental
  • Price
  • ORIC $4.77
  • SEAT $2.31
  • Analyst Decision
  • ORIC Strong Buy
  • SEAT Buy
  • Analyst Count
  • ORIC 9
  • SEAT 11
  • Target Price
  • ORIC $18.43
  • SEAT $5.58
  • AVG Volume (30 Days)
  • ORIC 969.8K
  • SEAT 1.9M
  • Earning Date
  • ORIC 05-05-2025
  • SEAT 05-06-2025
  • Dividend Yield
  • ORIC N/A
  • SEAT N/A
  • EPS Growth
  • ORIC N/A
  • SEAT N/A
  • EPS
  • ORIC N/A
  • SEAT 0.06
  • Revenue
  • ORIC N/A
  • SEAT $775,586,000.00
  • Revenue This Year
  • ORIC N/A
  • SEAT N/A
  • Revenue Next Year
  • ORIC N/A
  • SEAT $5.80
  • P/E Ratio
  • ORIC N/A
  • SEAT $41.05
  • Revenue Growth
  • ORIC N/A
  • SEAT 8.80
  • 52 Week Low
  • ORIC $3.90
  • SEAT $2.36
  • 52 Week High
  • ORIC $14.67
  • SEAT $6.09
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 37.10
  • SEAT 32.58
  • Support Level
  • ORIC $3.90
  • SEAT $2.36
  • Resistance Level
  • ORIC $5.38
  • SEAT $2.90
  • Average True Range (ATR)
  • ORIC 0.53
  • SEAT 0.23
  • MACD
  • ORIC 0.06
  • SEAT 0.01
  • Stochastic Oscillator
  • ORIC 41.97
  • SEAT 0.66

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: